Neuropathological findings in benign tremulous Parkinsonism

Movement Disorders

Volumn 28, Issue 2, 2013, Pages 145-152

  Selikhova, Marianna ^a,c   Kempster, Peter A ^a,b,d   Revesz, Tamas ^a   Holton, Janice L ^a,b   Lees, Andrew J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Benign tremulous; Parkin; Parkinson's disease; Substantia nigra; Tremor

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ORPHENADRINE; PARKIN; PROPRANOLOL;

ADULT; AGED; ARTICLE; AUTOPSY; BENIGN TREMULOUS PARKINSONISM; BRADYKINESIA; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DYSTONIC DISORDER; ESSENTIAL TREMOR; EXON; FAMILY HISTORY; FEMALE; FINGER TREMOR; GAIT DISORDER; GENE DELETION; HAND TREMOR; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; LIMB TREMOR; MALE; MENTAL DETERIORATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; POINT MUTATION; PRIORITY JOURNAL; REST TREMOR; SUBSTANTIA NIGRA; TREMOR; VISUAL HALLUCINATION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BRAIN; DATABASES, FACTUAL; ESSENTIAL TREMOR; FEMALE; HUMANS; HYPOKINESIA; LEWY BODIES; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; SUBSTANTIA NIGRA; TISSUE BANKS; UBIQUITIN-PROTEIN LIGASES;

EID: 84874206961     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25220     Document Type: Article

References (40)

1. Josephs KA, Matsumoto JY, Ahlskog E. Benign tremulous Parkinson's disease. Arch Neurol 2006;63:354-357.
2. Clarimón J, Pagonabarraga J, Paisán-Ruíz C, et al. Tremor dominant parkinsonism: clinical description and LRRK2 mutation screening. Mov Disord 2008;23:518-523.
3. Leventoglu A, Baysal AI. Benign tremulous Parkinson's disease. Acta Neurol Belg 2008:108;48-52.
4. Savica R, Matsumoto JY, Josephs KA, et al. Deep brain stimulation in benign tremulous parkinsonism. Arch Neurol 2011;68:1033-1036.
5. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord 2011;26:391-398.
6. Quinn NP, Schneider SA, Schwingenschuh P, et al. Tremor-some controversial aspects. Mov Disord 2011;26:18-23.
7. Jain S, Lo SE, Louis ED. Common misdiagnosis of a common neurological disorder. How are we misdiagnosing essential tremor. Arch Neurol 2006;63:1100-1104.
8. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of PD: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
9. Kempster PA, O'Sullivan SS, Holton JL, et al. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain 2010;133:1755-1762.
10. Lashley T, Holton JL, Gray E, et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol 2008;115:417-425.
11. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988;38:1402-1406.
12. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004;127:2657-2671.
13. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005;65:1863-1872.
14. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
15. Braak H, Bohl JR, Müller CM, et al. The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 2006;21:2042-2051.
16. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
17. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
18. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol 1991;30:637-649.
19. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007;130:1566-1576.
20. Selikhova M, Williams DR, Kempster PA, et al. A clinico-pathological study of subtypes in Parkinson's disease. Brain 2009;132:2947-2957.
21. Gowers WR. A manual of diseases of the nervous system. VolumeII. London:J. & A. Churchill;1888:608.
22. Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and distribution of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992;42:1554-1560.
23. Lewis SJ, Foltynie T, Blackwell AD, et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-348.
24. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 1985;35:522-526.
25. Jankovic J, Kapadia AS. Functional decline in Parkinson's disease. Arch Neurol 2001;58:1611-1615.
26. Rizzo G, Marconi S, Capellari S, et al. Benign tremulous parkinsonism in a patient with dardarin mutation. Mov Disord 2009;24:1399-1401.
27. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-892.
28. Yamamura Y, Hattori N, Matsumine H, et al. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000;22(Suppl 1):S87-S91.
29. Hayashi S, Wakabayashi K, Ishikawa A, et al. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 2000;15:884-888.
30. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.
31. Sasaki S, Shirata A, Yamane K, et al. Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions. Neurology 2004;63:678-682.
32. Pramstaller PP, Schlossmacher MG, Jacques TS, et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 2005;58:411-422.
33. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathological study of 20 cases. Neurology 2004;62:932-936.
34. Rajput AH, Robinson CA, Rajput AH. Benign tremulous parkinsonism: a clinico-pathological study. Mov Disord 2008;23:311-312.
35. Louis ED, Asabere N, Agnew A, et al. Rest tremor in advanced essential tremor: a post-mortem study of nine cases. J Neurol Neurosurg Psychiatry 2010;82:261-265.
36. Cohen O, Pullman S, Jurewicz E, et al. Rest tremor in patients with essential tremor: prevalence, clinical correlates and electrophysiological characteristics. Arch Neurol 2003;60:405-410.
37. Marek K, Seibyl J. Beta-CIT scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA-CIT and CALM-cit study: long-term imaging assessment. Neurology 2003;60(Suppl 1):A293.
38. Whone AL, Watts RL, Stoessl AJ, et al. Slower progression of Parkinson's disease with ropinorole versus levodopa: The REAL-PET study. Ann Neurol 2003;54:93-101.
39. Schwingenschuh P, Ruge D, Edwards MJ, et al. Distinguishing SWEDDs patients with asymmetrical resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010;25:560-569.
40. Bajaj NPS, Gontu V, Birchall J, et al. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 2010;81:1223-1228.